LONG COVID-19
Clinical trials for LONG COVID-19 explained in plain language.
Never miss a new study
Get alerted when new LONG COVID-19 trials appear
Sign up with your email to follow new studies for LONG COVID-19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a common drug ease long COVID? new trial launches
Disease control Recruiting nowThis study tests whether a low dose of sirolimus (rapamycin) can improve overall health and quality of life in adults with Long COVID. About 80 participants will receive either the drug or a placebo. The goal is to see if sirolimus helps reduce lingering symptoms after a COVID-19…
Matched conditions: LONG COVID-19
Phase: PHASE3 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Could anktiva ease long COVID? new safety trial begins
Symptom relief Recruiting nowThis study tests the safety of a drug called NAI (Anktiva) in 40 adults aged 18 to 70 who have Long COVID — meaning they still have symptoms after a confirmed COVID-19 infection. The main goal is to check for side effects and changes in vital signs over 30 days after treatment. I…
Matched conditions: LONG COVID-19
Phase: PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Symptom relief
Last updated May 22, 2026 14:01 UTC